Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.
Miller
M T
MT
Department of Ophthalmology, Eye and Ear Infirmary, University of Illinois, Chicago, Illinois 60612, USA.
Strömland
K
K
D005124:Eye Abnormalities / Q000139:chemically induced* / Q000266:history; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D049673:History, 20th Century; D006801:Humans; D007231:Infant, Newborn; D007918:Leprosy / Q000188:drug therapy; D017880:Limb Deformities, Congenital / Q000139:chemically induced / Q000453:epidemiology / Q000266:history; D008297:Male; D008431:Maternal-Fetal Exchange; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D011247:Pregnancy; D013548:Sweden / Q000453:epidemiology; D013723:Teratogens / Q000266:history / Q000633:toxicity*; D013792:Thalidomide / Q000266:history / Q000627:therapeutic use / Q000633:toxicity*
D013723:Teratogens; D013792:Thalidomide